What is the current size and annual growth rate of the transplant diagnostics market?
The transplant diagnostics market size has grown steadily in recent years. It will grow from $2.01 billion in 2024 to $2.07 billion in 2025 at a compound annual growth rate (CAGR) of 3.0%. The growth in the historic period can be attributed to development of hla typing, growth in organ transplantations, immunosuppressive therapy advancements, introduction of cross-matching techniques, regulatory standardization.
The transplant diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.75 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to patient-centric approaches, regulatory adaptations, rise in living donor transplants, personalized transplant medicine, growth in transplant procedures. Major trends in the forecast period include education and awareness programs, market expansion strategies, regulatory guidelines evolution, immunosuppressive therapy optimization, biomarker development.
Get Your Free Sample of The Global Transplant Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp
Which major factors have contributed to the expansion of the transplant diagnostics market?
The growing prevalence of chronic diseases is expected to propel the growth of the transplant diagnostics market going forward. Chronic diseases are long-lasting medical conditions that persist over time, often requiring ongoing management and treatment, and can include illnesses such as diabetes, heart disease, asthma, and arthritis. Chronic diseases are rising due to factors such as an aging population, increased prevalence of unhealthy lifestyles (including poor diet, physical inactivity, and smoking), and greater exposure to environmental pollutants. Chronic diseases require transplant diagnostics to assess organ function, compatibility, and the potential need for transplantation due to the long-term damage these conditions can cause to vital organs. For instance, in January 2022, according to research published by the American Cancer Society, a US-based health organization, in the US, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in 2022. It is about 1,670 fatalities each day. Therefore, the growing prevalence of chronic diseases is driving the growth of the transplant diagnostics market.
How is the transplant diagnostics market segmented?
The transplant diagnostics market covered in this report is segmented –
1) By Type: Reagent And Consumables, Instrument, Software And Services
2) By Transplant Type: Solid Organ, Stem Cell
3) By Organ: Kidney, Liver, Heart, Lung, Pancreas
4) By Technology: Non Molecular Assay, Molecular Assay
5) By End User: Hospitals And Transplant Centers, Research Laboratories AndTransplant Centers, Commercial Service Providers
Subsegments:
1) By Reagent And Consumables: PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials
2) By Instrument: Flow Cytometers, PCR Machines, Sequencers, Luminometers
3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report
Who are the top competitors in the transplant diagnostics market?
Major companies operating in the transplant diagnostics market include F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomérieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc
What are the top industry trends projected to impact the transplant diagnostics market?
Major companies operating in the transplant diagnostics market are focused on introducing advanced transplant diagnostics services to maximize their profits in the market. Advanced transplant diagnostic services refer to the use of novel and advanced diagnostic tools and technologies to improve the accuracy and efficiency of pre-transplant and post-transplant testing. For instance, in March 2023, Quest Diagnostics, a US-based medical laboratory company, launched Quest Advanced Specialized Transplant Services, an extensive collection of innovative diagnostics and support services created to increase access to lab tests for solid organ, human cell, and tissue transplants. It features a thorough selection of more than 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test results in the doctor’s electronic medical record (EMR), and round-the-clock support services, including medical consultation to ensure appropriate test selection and result interpretation affecting care. The new services build on Quest’s previous offering in transplant testing with new capabilities. These capabilities include new patient-customized information packets to help educate patients on the process and help Quest’s phlebotomists fast-track testing for patients visiting one of Quest’s 2,100 patient service centers. Results for some tests can be obtained within 8–24 hours.
How do regional factors impact the transplant diagnostics market, and which region is the largest contributor?
North America was the largest region in the transplant diagnostics market in 2024. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Transplant Diagnostics Market Report 2025 Offer?
The transplant diagnostics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Transplant diagnostics are the tests conducted before relocation/ transplantation of the donor organ to the recipient patient. Histocompatibility and immunogenetics are the main topics of transplantation diagnostics in the context of organ transplantation and hematopoietic stem cell transplantation.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2481
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
